Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
L. Taranto Montemurro (Chestnut Hill , United States of America). Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea. International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside

Member's Comments

No comment yet.

Related content which might interest you: Non-CPAP therapies in obstructive sleep apnoea Source: Guideline 2011 Year: 2011 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Surgical approaches to the treatment of obstructive sleep apnea Source: Virtual Congress 2020 – New technologies for the management of COPD and obstructive sleep apnea and the diagnosis of lung cancer Year: 2020 Change in PLMS after treatment of obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Advances in the surgical treatment of obstructive sleep apnoea Source: International Congress 2017 – Multidisciplinary management of sleep apnoea Year: 2017 Clinical assessment of obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006 ACE-inhibitors and obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 358s Year: 2005 Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018 Year: 2019 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 From the laboratory to the bedside: the pharmacotherapy of obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021 Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study Source: Eur Respir J 2013; 41: 360-367 Year: 2013 Improving adherence to treatment in patients with obstructive sleep apnoea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 The role of bi-level therapy in obstructive sleep apnoea Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008 Selection of surgical approach in treatment of obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 572s Year: 2004 Treating obstructive sleep apnoea to improve control of hypertension Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights Year: 2014 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 Telemedicine(TM)-based strategy for management of obstructive sleep apnea (OSA): Virtual sleep unit Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 Pre-operative screening for obstructive sleep apnoea Source: Eur Respir Rev 2017; 26: 160012 Year: 2017